Children's Brain Tumor Foundation explains the importance of their research and programs.
Why is it so important to support CBTF's research and programs? Watch this video featuring families, survivors, and some of our greatest supporters to find out why.
FDA Approves Eflornithine for Children, Adults With High-Risk Neuroblastoma
December 14th 2023Eflornithine (Iwilfin) received FDA approval to reduce the risk for relapse in pediatric and adult patients with high-risk neuroblastoma, making it the first therapy to reduce risk for relapse in children with the disease.